Cantabio Pharmaceuticals Inc. Income Statement

Ask AI

Financial Statements

In USD, except per-share amounts

	FY2018 12 months to Mar 31, 2018	FY2017 12 months to Mar 31, 2017	FY2016 12 months to Mar 31, 2016	FY2015 12 months to Mar 31, 2015	FY2014 12 months to Mar 31, 2014
Revenues
Filing and registration fees
Professional fees
Advertising fees
Business licenses and fees
Rent - related party
Operating Costs and Expenses
Research and development expense
Management fees
General and administrative expenses
Management services
Total operating expenses
LOSS FROM OPERATIONS
Total operating costs and expenses
Income (loss) from operations
Income tax provision

Other Income and Expenses
Grant income
Other income
Interest expense
Change in fair value of embedded derivative
Gain (loss) on extinguishment of debt
Gain (loss) on foreign exchange
Total other income and (expenses)
Net income (loss)

Basic and diluted earnings (loss) per share
Weighted average common shares outstanding - basic and diluted

Comments